Shionogi Competitors and Similar CompaniesClear all
Shionogi's competitors and similar companies include Amneal Pharmaceuticals, Lilly, Bayer and Astellas Pharma.
 Shionogi Shionogi (塩野義製薬株式会社) is a pharmaceutical company developing treatments for infectious, pain, and chronic liver diseases. |  Amneal Pharmaceuticals Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas. |  Lilly Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products. |  Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. | ||
Founding Date | Founding Date 1878 | Founding Date 2002 | Founding Date 1876 | Founding Date 1863 | Founding Date 1923 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Osaka, JP HQ Beijing, CN Hong Kong, HK Amagasaki, JP Amagasaki, JP Kanegasaki, JP Misato, JP see more | Locations Bridgewater Township, US HQ Gröbenzell, DE Ahmedabad, IN Ahmedabad, IN Ahmedabad, IN Dahej, IN Mahabubnagar, IN see more | Locations Indianapolis, US HQ Buenos Aires, AR Sydney, AU Wien, AT Brussel, BE São Paulo, BR Toronto, CA see more | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | |
Employees | Employees 4,955 | Employees 8,1005% increase | Employees 47,0009% increase | Employees 88,5021% decrease | Employees 14,754 |
Valuation ($) | Valuation ($) 12.3 b | Valuation ($) 2.6 b | Valuation ($) 903.4 b | Valuation ($) 27.1 b | Valuation ($) 20.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥499.7b (FY, 2026) | Revenue (est.) $3b (FY, 2025) | Revenue (est.) $65.2b (FY, 2025) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) ¥2.1t (FY, 2026) |
Cost of goods | Cost of goods ¥55.5b (FY, 2026) | Cost of goods $1.9b (FY, 2025) | Cost of goods $11.1b (FY, 2025) | Cost of goods €14b (FY, 2025) | Cost of goods ¥213.8b (FY, 2026) |
Gross profit | Gross profit ¥491.3b (FY, 2026) | Gross profit $1.1b (FY, 2025) | Gross profit $54.1b (FY, 2025) | Gross profit €32.5b (FY, 2025) | Gross profit ¥2t (FY, 2026) |
Net income | Net income ¥205.9b (FY, 2026) | Net income $127.9m (FY, 2025) | Net income $20.6b (FY, 2025) | Net income (€3.6b) (FY, 2025) | Net income ¥291.6b (FY, 2026) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries N/A | Countries 120 (FY, 2021) | Countries 83 (FY, 2021) | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised $ 4.7m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 3.5b | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Amneal Pharmaceuticals
HQ
Bridgewater Township, US
Employees
8,100↑ 5% increase
Amneal Pharmaceuticals is a company that specializes in developing, manufacturing, and distributing of generic products which include complex dosage forms in a broad range of therapeutic areas.
View companyLilly
HQ
Indianapolis, US
Employees
47,000↑ 9% increase
Eli Lilly is a company that discovers, develops, manufactures, and markets pharmaceutical products.
View company
Bayer
HQ
Leverkusen, DE
Employees
88,502↓ 1% decrease
Bayer is a life sciences company specializing in healthcare and nutrition.
View companyAstellas Pharma
HQ
Tokyo, JP
Employees
14,754
Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
View company